Approval · Notice of Compliance 18428 · 2016
RELISTOR: Notice of Compliance 18428
Issued August 25, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18428
- Date
- August 25, 2016
- Company
- Salix Pharmaceuticals IncBridgewater, New Jersey, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- TO REGISTER A NEW SITE FOR THE MANUFACTURE, TESTING AND PACKAGING OF THE 20 MG/ML DRUG PRODUCT (dp) FILLED INTO SINGLE-USE GLASS VIALS
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RELISTOR | Not yet assigned | — |
Medicinal ingredients
- METHYLNALTREXONE BROMIDE 20 MG per ML